251 related articles for article (PubMed ID: 32033594)
1. Diagnostic accuracy of sFlt1/PlGF ratio as a marker for preeclampsia.
Nikuei P; Rajaei M; Roozbeh N; Mohseni F; Poordarvishi F; Azad M; Haidari S
BMC Pregnancy Childbirth; 2020 Feb; 20(1):80. PubMed ID: 32033594
[TBL] [Abstract][Full Text] [Related]
2. Maternal Serum Angiogenic Factor sFlt-1 to PlGF Ratio in Preeclampsia: A Useful Marker for Differential Diagnosis and Prognosis Evaluation in Chinese Women.
Lou WZ; Jiang F; Hu J; Chen XX; Song YN; Zhou XY; Liu JT; Bian XM; Gao JS
Dis Markers; 2019; 2019():6270187. PubMed ID: 31396294
[TBL] [Abstract][Full Text] [Related]
3. Values of serum sFlt-1, PLGF levels, and sFlt-1/PLGF ratio in diagnosis and prognosis evaluation of preeclamptic patients.
Zhu X; Chen L; Li R
Clin Exp Hypertens; 2020 Oct; 42(7):601-607. PubMed ID: 32338084
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of preeclampsia and fetal growth restriction with the sFlt-1/PlGF ratio: Diagnostic accuracy of the automated immunoassay Kryptor®.
Dröge LA; Höller A; Ehrlich L; Verlohren S; Henrich W; Perschel FH
Pregnancy Hypertens; 2017 Apr; 8():31-36. PubMed ID: 28501276
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of soluble fms-like tyrosine kinase-1 against placental growth factor for preeclampsia in a Chinese pregnant women population.
Yu F; Bai Q; Zhang S; Jiang Y
J Clin Lab Anal; 2019 Jun; 33(5):e22861. PubMed ID: 30758082
[TBL] [Abstract][Full Text] [Related]
6. [Use of sFlt-1/PlGF ratio in preeclampsia : a monocentric retrospective analysis].
Verbeurgt L; Chantraine F; De Marchin J; Minon JM; Nisolle M
Rev Med Liege; 2017 Sep; 72(9):393-398. PubMed ID: 28892314
[TBL] [Abstract][Full Text] [Related]
7. The feasibility of soluble Fms-Like Tyrosine kinase-1 (sFLT-1) and Placental Growth Factor (PlGF) ratio biomarker in predicting preeclampsia and adverse pregnancy outcomes among medium to high risk mothers in Kuala Lumpur, Malaysia.
Aminuddin NA; Sutan R; Mahdy ZA; Rahman RA; Nasuruddin DN
PLoS One; 2022; 17(3):e0265080. PubMed ID: 35275947
[TBL] [Abstract][Full Text] [Related]
8. Copeptin and mid-regional pro-atrial natriuretic peptide in women with suspected or confirmed pre-eclampsia: comparison with sFlt-1/PlGF ratio.
Neuman RI; van der Meer MMA; Saleh L; van den Berg SAA; van den Meiracker AH; Danser AHJ; Visser W
Ultrasound Obstet Gynecol; 2020 Dec; 56(6):872-878. PubMed ID: 31975510
[TBL] [Abstract][Full Text] [Related]
9. Prediction of preeclampsia with angiogenic biomarkers. Results from the prospective Odense Child Cohort.
Andersen LB; Dechend R; Jørgensen JS; Luef BM; Nielsen J; Barington T; Christesen HT
Hypertens Pregnancy; 2016 Aug; 35(3):405-19. PubMed ID: 27159383
[TBL] [Abstract][Full Text] [Related]
10. The predictive value of the sFlt-1/PlGF ratio on short-term absence of preeclampsia and maternal and fetal or neonatal complications in twin pregnancies.
Saleh L; Tahitu SIM; Danser AHJ; van den Meiracker AH; Visser W
Pregnancy Hypertens; 2018 Oct; 14():222-227. PubMed ID: 29678353
[TBL] [Abstract][Full Text] [Related]
11. The New Possibilities in Early Diagnosis of Preeclampsia by Soluble fms-Like Tyrosine Kinase-1 and Placental Growth Factor in 16-20 Weeks Gestation.
Benovská M; Opluštilová A; Pinkavová J; Hodická Z; Cermáková Z
Lab Med; 2018 Mar; 49(2):112-117. PubMed ID: 29267975
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of sFlt-1, PlGF, sFlt-1/PlGF ratio and PAPP-A for late-onset preeclampsia and IUGR between 32 and 37 weeks of pregnancy.
Birdir C; Droste L; Fox L; Frank M; Fryze J; Enekwe A; Köninger A; Kimmig R; Schmidt B; Gellhaus A
Pregnancy Hypertens; 2018 Apr; 12():124-128. PubMed ID: 29674192
[TBL] [Abstract][Full Text] [Related]
13. Correlation of Kryptor and Elecsys® immunoassay sFlt-1/PlGF ratio on early diagnosis of preeclampsia and fetal growth restriction: A case-control study.
Simón E; Herraiz I; Villalaín C; Gómez-Arriaga PI; Quezada MS; López-Jiménez EA; Galindo A
Pregnancy Hypertens; 2020 Apr; 20():44-49. PubMed ID: 32172169
[TBL] [Abstract][Full Text] [Related]
14. Serum sFlt-1/PlGF ratio has better diagnostic ability in early- compared to late-onset pre-eclampsia.
Chuah TT; Tey WS; Ng MJ; Tan ETH; Chern B; Tan KH
J Perinat Med; 2018 Dec; 47(1):35-40. PubMed ID: 29708884
[TBL] [Abstract][Full Text] [Related]
15. sFlt-1, PlGF, sFlt-1/PlGF ratio and uterine artery Doppler for preeclampsia diagnostics.
Tarasevičienė V; Grybauskienė R; Mačiulevičienė R
Medicina (Kaunas); 2016; 52(6):349-353. PubMed ID: 27940029
[TBL] [Abstract][Full Text] [Related]
16. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X
Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913
[TBL] [Abstract][Full Text] [Related]
17. Should angiogenic markers be included in diagnostic criteria of superimposed pre-eclampsia in women with chronic hypertension?
Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
Ultrasound Obstet Gynecol; 2022 Feb; 59(2):192-201. PubMed ID: 34165863
[TBL] [Abstract][Full Text] [Related]
18. Prediction of adverse maternal outcomes of early severe preeclampsia.
Mirkovic L; Tulic I; Stankovic S; Soldatovic I
Pregnancy Hypertens; 2020 Oct; 22():144-150. PubMed ID: 32979729
[TBL] [Abstract][Full Text] [Related]
19. Angiogenic profile in the Finnish Genetics of Pre-Eclampsia Consortium (FINNPEC) cohort.
Jääskeläinen T; Heinonen S; Hämäläinen E; Pulkki K; Romppanen J; Laivuori H;
Pregnancy Hypertens; 2018 Oct; 14():252-259. PubMed ID: 29803331
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the diagnostic utility of the sFlt-1/PlGF ratio versus PlGF alone for the detection of preeclampsia/HELLP syndrome.
Stepan H; Hund M; Gencay M; Denk B; Dinkel C; Kaminski WE; Wieloch P; Semus B; Meloth T; Dröge LA; Verlohren S
Hypertens Pregnancy; 2016 Aug; 35(3):295-305. PubMed ID: 27028698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
